Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

Laparoscopic hysterectomy to manage uterine rupture due to placenta percreta in the first trimester: A case report.

Lee F, Zahn K, Knittel AK, Morse J, Louie M.

Case Rep Womens Health. 2019 Nov 29;25:e00165. doi: 10.1016/j.crwh.2019.e00165. eCollection 2020 Jan.

2.

The SYDNEY Device Study: A Multicenter, Randomized, Open-Label Usability Study of a 2-mL Alirocumab Autoinjector Device.

Frias JP, Koren MJ, Loizeau V, Merino-Trigo A, Louie MJ, Raudenbush MA, Batsu I.

Clin Ther. 2019 Dec 23. pii: S0149-2918(19)30569-7. doi: 10.1016/j.clinthera.2019.11.008. [Epub ahead of print]

3.

The Effect of Bariatric Surgery on Perioperative Complications After Hysterectomy.

Whitley J, Moore KJ, Carey ET, Louie M.

J Minim Invasive Gynecol. 2019 Dec 13. pii: S1553-4650(19)31348-2. doi: 10.1016/j.jmig.2019.12.011. [Epub ahead of print]

PMID:
31843695
4.

Risk factors for repeat hernia repair in women of childbearing age.

Louie M, Strassle PD, Moulder JK, Overby W.

Hernia. 2019 Nov 26. doi: 10.1007/s10029-019-02077-6. [Epub ahead of print]

PMID:
31773551
5.

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.

Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY.

J Am Heart Assoc. 2019 Oct;8(19):e013229. doi: 10.1161/JAHA.119.013229. Epub 2019 Sep 26.

6.

Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials.

Tinahones FJ, Laufs U, Cariou B, Louie MJ, Yang J, Thompson D, Leiter LA.

Diabetes Metab. 2019 Sep 15:101120. doi: 10.1016/j.diabet.2019.101120. [Epub ahead of print]

PMID:
31533069
7.

Enantiomer of the novel flexible heteroarotinoid, SL-1-09, blocks cell cycle progression in breast cancer cells.

Ginn E, Baek J, Zou H, Fallatah MMJ, Liu S, Sevigny MB, Louie M.

Eur J Pharmacol. 2019 Nov 5;862:172634. doi: 10.1016/j.ejphar.2019.172634. Epub 2019 Sep 5.

PMID:
31494077
8.

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.

Roe MT, Li QH, Bhatt DL, Bittner VA, Diaz R, Goodman SG, Harrington RA, Jukema JW, Lopez-Jaramillo P, Lopes RD, Louie MJ, Moriarty PM, Szarek M, Vogel R, White HD, Zeiher AM, Baccara-Dinet MT, Steg PG, Schwartz GG.

Circulation. 2019 Nov 5;140(19):1578-1589. doi: 10.1161/CIRCULATIONAHA.119.042551. Epub 2019 Sep 2.

9.

Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome - The ODYSSEY J-IVUS Trial.

Ako J, Hibi K, Tsujita K, Hiro T, Morino Y, Kozuma K, Shinke T, Otake H, Uno K, Louie MJ, Takagi Y, Miyauchi K.

Circ J. 2019 Sep 25;83(10):2025-2033. doi: 10.1253/circj.CJ-19-0412. Epub 2019 Aug 20.

10.

Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα.

Bloomfield M, Louie MC.

Sci Rep. 2019 Aug 20;9(1):12135. doi: 10.1038/s41598-019-46912-3.

11.

Sex Differences in the Use of Statins in Community Practice.

Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005562. doi: 10.1161/CIRCOUTCOMES.118.005562. Epub 2019 Aug 16.

PMID:
31416347
12.

Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies.

Raal FJ, Tuomilehto J, Sposito AC, Fonseca FA, Averna M, Farnier M, Santos RD, Ferdinand KC, Wright RS, Navarese EP, Lerch DM, Louie MJ, Lee LV, Letierce A, Robinson JG.

J Clin Lipidol. 2019 Sep - Oct;13(5):735-743. doi: 10.1016/j.jacl.2019.06.006. Epub 2019 Jun 29.

13.

Artificial intelligence and augmented reality in gynecology.

Moawad G, Tyan P, Louie M.

Curr Opin Obstet Gynecol. 2019 Oct;31(5):345-348. doi: 10.1097/GCO.0000000000000559.

PMID:
31259843
14.

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.

Ray KK, Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Louie MJ, Bujas-Bobanovic M, Minini P, Eckel RH, Cannon CP.

Atherosclerosis. 2019 Sep;288:194-202. doi: 10.1016/j.atherosclerosis.2019.06.896. Epub 2019 Jun 8.

15.

Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.

Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, Robinson JG, Roger VL, Wilson PWF, Goldberg AC, Koren A, Louie MJ, Peterson ED.

Am Heart J. 2019 Aug;214:113-124. doi: 10.1016/j.ahj.2019.05.009. Epub 2019 May 22.

PMID:
31202098
16.

PCSK9 inhibition in patients with and without prior myocardial infarction or ischemic stroke: A pooled analysis of nine randomized-controlled studies of alirocumab.

Bruckert E, Kereiakes DJ, Koren MJ, Louie MJ, Letierce A, Miller K, Cannon CP.

J Clin Lipidol. 2019 May - Jun;13(3):443-454. doi: 10.1016/j.jacl.2019.04.005. Epub 2019 Apr 10.

17.

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.

Coombes RC, Page K, Salari R, Hastings RK, Armstrong A, Ahmed S, Ali S, Cleator S, Kenny L, Stebbing J, Rutherford M, Sethi H, Boydell A, Swenerton R, Fernandez-Garcia D, Gleason KLT, Goddard K, Guttery DS, Assaf ZJ, Wu HT, Natarajan P, Moore DA, Primrose L, Dashner S, Tin AS, Balcioglu M, Srinivasan R, Shchegrova SV, Olson A, Hafez D, Billings P, Aleshin A, Rehman F, Toghill BJ, Hills A, Louie MC, Lin CJ, Zimmermann BG, Shaw JA.

Clin Cancer Res. 2019 Jul 15;25(14):4255-4263. doi: 10.1158/1078-0432.CCR-18-3663. Epub 2019 Apr 16.

PMID:
30992300
18.

Mentoring millennials in surgical education.

Louie M, Moulder JK, Wright K, Siedhoff M.

Curr Opin Obstet Gynecol. 2019 Aug;31(4):279-284. doi: 10.1097/GCO.0000000000000546.

PMID:
30973375
19.

Effect of length of hospital stay on infection and readmission after minimally invasive hysterectomy.

Schiff LD, Voltzke KJ, Strassle PD, Louie M, Carey ET.

Int J Gynaecol Obstet. 2019 Jun;145(3):293-299. doi: 10.1002/ijgo.12812. Epub 2019 Apr 11.

PMID:
30929251
20.

Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.

Bradley CK, Wang TY, Li S, Robinson JG, Roger VL, Goldberg AC, Virani SS, Louie MJ, Lee LV, Peterson ED, Navar AM.

J Am Heart Assoc. 2019 Apr 2;8(7):e011765. doi: 10.1161/JAHA.118.011765.

21.

Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry).

Lowenstern A, Navar AM, Li S, Virani SS, Goldberg AC, Louie MJ, Lee LV, Peterson ED, Wang TY.

Am J Cardiol. 2019 Apr 1;123(7):1011-1018. doi: 10.1016/j.amjcard.2018.12.031. Epub 2019 Jan 4. Review.

PMID:
30660354
22.

Use of Historic Surgical Times to Predict Duration of Hysterectomy: Stratifying by Uterine Weight.

Cassling C, Shay R, Strassle PD, Voltzke K, Schiff L, Louie M, Carey E.

J Minim Invasive Gynecol. 2019 Nov - Dec;26(7):1327-1333. doi: 10.1016/j.jmig.2019.01.003. Epub 2019 Jan 10.

PMID:
30639320
23.

Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2.

Zou H, Sevigny MB, Liu S, Madden DT, Louie MC.

Cancer Lett. 2019 Feb 28;443:157-166. doi: 10.1016/j.canlet.2018.11.022. Epub 2018 Nov 29.

24.

Recent Advances in Technology and Its Applications to Pediatric Emergency Care.

Louie MC, Chang TP, Grundmeier RW.

Pediatr Clin North Am. 2018 Dec;65(6):1229-1246. doi: 10.1016/j.pcl.2018.07.013. Review.

PMID:
30446059
25.

Opioid Use in the Postoperative Arena: Global Reduction in Opioids After Surgery Through Enhanced Recovery and Gynecologic Surgery.

Moulder JK, Boone JD, Buehler JM, Louie M.

Clin Obstet Gynecol. 2019 Mar;62(1):67-86. doi: 10.1097/GRF.0000000000000410. Review.

PMID:
30407228
26.

Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.

Lowenstern AM, Li S, Navar AM, Roger VL, Robinson JG, Goldberg AC, Virani SS, Lee LV, Wilson PWF, Louie MJ, Peterson ED, Wang TY.

J Am Heart Assoc. 2018 Sep 18;7(18):e009251. doi: 10.1161/JAHA.118.009251.

27.

Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial.

Taskinen MR, Del Prato S, Bujas-Bobanovic M, Louie MJ, Letierce A, Thompson D, Colhoun HM.

Atherosclerosis. 2018 Sep;276:124-130. doi: 10.1016/j.atherosclerosis.2018.07.017. Epub 2018 Jul 21.

28.

Electrodeposited Gold on Carbon-Fiber Microelectrodes for Enhancing Amperometric Detection of Dopamine Release from Pheochromocytoma Cells.

Barlow ST, Louie M, Hao R, Defnet PA, Zhang B.

Anal Chem. 2018 Aug 21;90(16):10049-10055. doi: 10.1021/acs.analchem.8b02750. Epub 2018 Aug 6.

PMID:
30047726
29.

Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.

Louie M, Strassle PD, Moulder JK, Dizon AM, Schiff LD, Carey ET.

Am J Obstet Gynecol. 2018 Nov;219(5):480.e1-480.e8. doi: 10.1016/j.ajog.2018.06.015. Epub 2018 Jun 28.

PMID:
29959931
30.

Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.

Lowenstern A, Li S, Navar AM, Virani S, Lee LV, Louie MJ, Peterson ED, Wang TY.

Am Heart J. 2018 Jun;200:118-124. doi: 10.1016/j.ahj.2018.03.011. Epub 2018 Mar 24.

31.

Ureteral Stent Discomfort and Its Management.

Fischer KM, Louie M, Mucksavage P.

Curr Urol Rep. 2018 Jun 11;19(8):64. doi: 10.1007/s11934-018-0818-8. Review.

PMID:
29892783
32.

Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.

Ginsberg HN, Farnier M, Robinson JG, Cannon CP, Sattar N, Baccara-Dinet MT, Letierce A, Bujas-Bobanovic M, Louie MJ, Colhoun HM.

Diabetes Ther. 2018 Jun;9(3):1317-1334. doi: 10.1007/s13300-018-0439-8. Epub 2018 May 19.

33.

Home Oxygen Therapy for Bronchiolitis: An Evaluation of the Primary Care Providers' Experience at Sea Level.

Dunbar EE, Macy ML, Cranford JA, Sroufe N, Lozon M, Louie MC.

Clin Pediatr (Phila). 2018 Oct;57(11):1304-1309. doi: 10.1177/0009922818774342. Epub 2018 May 17.

PMID:
29772916
34.

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.

Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.

J Am Heart Assoc. 2018 May 8;7(10). pii: e008546. doi: 10.1161/JAHA.118.008546.

35.

Correction to: Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.

Bays HE, Rosenson RS, Baccara-Dinet MT, Louie MJ, Thompson D, Kees Hovingh G.

Cardiovasc Drugs Ther. 2018 Apr;32(2):181. doi: 10.1007/s10557-018-6792-z.

36.

The case against endometrial ablation for treatment of heavy menstrual bleeding.

Louie M, Wright K, Siedhoff MT.

Curr Opin Obstet Gynecol. 2018 Aug;30(4):287-292. doi: 10.1097/GCO.0000000000000463. Review.

PMID:
29708902
37.

Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials.

Bays HE, Rosenson RS, Baccara-Dinet MT, Louie MJ, Thompson D, Hovingh GK.

Cardiovasc Drugs Ther. 2018 Apr;32(2):175-180. doi: 10.1007/s10557-018-6784-z. Erratum in: Cardiovasc Drugs Ther. 2018 Apr 27;:.

38.

Immediate operation for acute type A aortic dissection complicated by visceral or peripheral malperfusion.

Chiu P, Tsou S, Goldstone AB, Louie M, Woo YJ, Fischbein MP.

J Thorac Cardiovasc Surg. 2018 Jul;156(1):18-24.e3. doi: 10.1016/j.jtcvs.2018.01.096. Epub 2018 Feb 21.

39.

Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.

Toth PP, Dwyer JP, Cannon CP, Colhoun HM, Rader DJ, Upadhyay A, Louie MJ, Koren A, Letierce A, Mandel J, Banach M.

Kidney Int. 2018 Jun;93(6):1397-1408. doi: 10.1016/j.kint.2017.12.011. Epub 2018 Mar 8.

40.

Total Laparoscopic Hysterectomy and Bilateral Salpingo-Oophorectomy for a 6095-g Myomatous Uterus in a Patient of the Jehovah's Witness Faith.

Siedhoff MT, Louie M, Misal M, Moulder JK.

J Minim Invasive Gynecol. 2019 Jan;26(1):25-28. doi: 10.1016/j.jmig.2018.02.018. Epub 2018 Mar 5.

PMID:
29518583
41.

Effect of alirocumab on lipids and lipoproteins in individuals with metabolic syndrome without diabetes: Pooled data from 10 phase 3 trials.

Henry RR, Müller-Wieland D, Taub PR, Bujas-Bobanovic M, Louie MJ, Letierce A, Ginsberg HN.

Diabetes Obes Metab. 2018 Jul;20(7):1632-1641. doi: 10.1111/dom.13273. Epub 2018 Mar 25.

42.

Physician perspectives on vaccination and diagnostic testing in children with gastroenteritis: A primary care physician survey.

Sperou AJ, Dickinson JA, Lee B, Louie M, Pang XL, Chui L, Vanderkooi OG, Freedman SB; Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE).

Paediatr Child Health. 2017 Sep;22(6):317-321. doi: 10.1093/pch/pxx078. Epub 2017 Jun 17.

43.

Accuracy of Smartphone-Based Pulse Oximetry Compared with Hospital-Grade Pulse Oximetry in Healthy Children.

Tomlinson S, Behrmann S, Cranford J, Louie M, Hashikawa A.

Telemed J E Health. 2018 Jul;24(7):527-535. doi: 10.1089/tmj.2017.0166. Epub 2017 Dec 7.

PMID:
29215972
44.

Identification of Enteric Viruses in Oral Swabs from Children with Acute Gastroenteritis.

Zhuo R, Parsons BD, Lee BE, Drews SJ, Chui L, Louie M, Crago B, Freedman SB, Ali S, Pang X.

J Mol Diagn. 2018 Jan;20(1):56-62. doi: 10.1016/j.jmoldx.2017.09.003. Epub 2017 Oct 19.

45.
46.

Steroid hormone receptors as prognostic markers in breast cancer.

Louie MC, Sevigny MB.

Am J Cancer Res. 2017 Aug 1;7(8):1617-1636. eCollection 2017. Review.

47.

Novel flexible heteroarotinoid, SL-1-18, promotes ERα degradation to inhibit breast cancer cell growth.

Fallatah MM, Liu S, Sevigny MB, Zou H, Louie MC.

Cancer Lett. 2017 Nov 1;408:82-91. doi: 10.1016/j.canlet.2017.08.026. Epub 2017 Aug 25.

PMID:
28844711
48.

Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model.

Louie M, Spencer J, Wheeler S, Ellis V, Toubia T, Schiff LD, Siedhoff MT, Moulder JK.

Int J Gynaecol Obstet. 2017 Nov;139(2):121-129. doi: 10.1002/ijgo.12293. Epub 2017 Sep 1. Review.

PMID:
28796898
49.

Cost-effectiveness of treatments for heavy menstrual bleeding.

Spencer JC, Louie M, Moulder JK, Ellis V, Schiff LD, Toubia T, Siedhoff MT, Wheeler SB.

Am J Obstet Gynecol. 2017 Nov;217(5):574.e1-574.e9. doi: 10.1016/j.ajog.2017.07.024. Epub 2017 Jul 25.

PMID:
28754438
50.

The role of simulation and warm-up in minimally invasive gynecologic surgery.

Moulder JK, Louie M, Toubia T, Schiff LD, Siedhoff MT.

Curr Opin Obstet Gynecol. 2017 Aug;29(4):212-217. doi: 10.1097/GCO.0000000000000368. Review.

PMID:
28520585

Supplemental Content

Support Center